Abstract
Three new cases of an unusual subtype of hepatocellular carcinoma (HCC) referred to as fibrolamellar hepatocarcinoma (FLHC) recently seen at our institution are described. This report focuses on the clinical, radiologic, and pathologic features of this rare subset of HCC. All three patients were under 30 years of age with no previous history of hepatitis or cirrhosis. Each had had subacute symptoms for 5 months to 1 year before medical attention was sought and/or diagnosis of FLHC was established. There was no reliable correlation with oral contraceptive use in the 2 female patients. Serum alpha-1-fetoprotein levels were normal with only mild elevation of liver enzymes. The CT features, although not specific, were suggestive of an aggressive tumor with amorphous calcification in 2 of the 3 cases. Angiographically all tumors were hypervascular without any evidence of arterioportal shunting or venous invasion of major vessels. The clinical and radiologic recognition of these tumors is important since the surgical resectibility rate and 2- and 5-year survival rates are higher than those applicable to conventional HCC.
Similar content being viewed by others
References
Craig JR, Peters RL, Edmundson HA, Omata M: Fibrolamellar carcinoma of liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.Cancer 46:372–379, 1980
Berman MM, Libby NP, Foster JH: Hepatocellular carcinoma: polygonal cell type with fibrous stroma — an atypical variant with a favorable prognosis.Cancer 46:1448–1455, 1980
Fahri DC, Shikes RH, Silverberg SG: Ultrastructure of fibro lamellar oncocytic hepatoma.Cancer 50:702–709, 1980
Lefkowitch JH, Arborgh BAM, Scheuer PJ: Oxyphilic granular hepatocytes: mitochondrion rich liver cells in hepatic disease.Am J Clin Pathol 74:432–441, 1980
Fahri DC, Shikes RH, Murari PJ, Silverberg SJ: Hepatocellular carcinoma in young adults.Cancer 52:1516–1525, 1983
Lack EE, Neave C, Vawter GF: Hepatocellular carcinoma: review of 32 cases in childhood and adolescent.Cancer 52:1510–1515, 1983
Stromeyer FW, Ishak KG, Gerber MA: Ground glass cells in hepatocellular carcinoma.Am J Clin Pathol 74:254–258, 1980
Albukerk J: Hepatocellular carcinoma in young adults.NY State J Med 81:1341–1344, 1981
Wang LK, Link DP, Frey CF, Ruebner BH, Tesluk H, Primstone NR: Fibrolamellar hepatocarcinoma: radiology, management and pathology.AJR 139:172–175, 1982
Peters RL: Pathology of hepatocellular carcinoma. In Okuda K Peters RL (eds):Hepatocellular Carcinoma. New York: John Wiley and Sons, 1976
Foster JH, Berman MM: Solid liver tumors. In Ebert PA (ed):Major Problems in Clinical Surgery, vol 22. Philadelphia: WB Saunders, 1977, pp 5–8, 86–97, 111–128
Edmondson HA: Tumors of liver and intrahepatic bile ducts. In:Atlas of Tumor Pathology, section 7, fascicle 2. Washington DC: Armed Forces Institute of Pathology, 1958
Okuda K, Musha H, Yoshida T, Kanda Y, Yamazaki T, Jinnouchi S, Moriyama M, Kawaguchi S, Kubi Y, Shimokawa Y, Kojiro M, Kuratomi S, Sakamoto K Nakashima T: Demonstration of growing cast of hepatocellular carcinoma in the portal vein by celiac angiography: “the thread and streaks sign.”Radiology 117:303–309, 1975
Reuter SR, Redman HC, Siders DB: The spectrum of angiographic findings in hepatoma.Radiology 94:89–94, 1970
Kunstlinger F, Federle MP, Moss AA, Marks W: Computed tomography of hepatocellular carcinoma.AJR 134:431–437, 1980
Itai Y, Nishikawa J, Tasaka A: Computed tomography in the evaluation of hepatocellular carcinoma.Radiology 13:165–170, 1979
Hosoki T, Chatani M, Mori S: Dynamic computed tomography of hepatocellular carcinoma.AJR 139:1099–1106, 1982
Takashima T, Matsui O, Suzuki M, Ida M: Diagnosis and screening of small hepatocellular carcinoma.Radiology 145:635–638, 1980
Matsui O, Kadoya M, Suzuki M, Inoue K, Ida H, Ida M, Takashima T: Dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms.Radiology 146:721–727, 1983
Bernardino M, Lewis E: Imaging hepatic neoplasms.Cancer 50:2666–2671, 1982
Inamoto K, Sugiki K, Yamasaki H, Nakao N, Takashi M: Computed tomography and angiography of hepatocellular carcinoma.J Comput Assist Tomogr 4:832–839, 1980
Dunnick NR, Ihde DC, Dopman JL, Richard-Bates H: Computed tomography in primary hepatocellular carcinoma.J Comput Assist Tomogr 4:59–60, 1980
Hosoki T, Toyonaga Y, Araki Y, Mori S: Dynamic computed tomography of isodense hepatocellular carcinoma.J Comput Assist Tomogr 8:263–268, 1984
Edmondson HA: Differential diagnosis of tumor and tumor like lesions of the liver in infancy and childhood.Arch Dis Child 1:168–186, 1956
Anthony PP: Primary carcinoma of the liver: study of 282 cases in Uganda Africans.J Pathol 110:37–48, 1973
Gibson JR:Histological Typing of Tumors of the Liver, Biliary Tract and Pancreas. Geneva: World Health Organization, 1978
Neuberger J, Portmann B, Nunnerley HB, Laws JW, Davis M, William R: Oral-contraceptive-associated liver tumors: occurrence of difficulties in diagnosis.Lancet 1:273–276, 1980
Davis M, Portmann B, Searle M, Wright R: Histologic evidence of carcinoma in a hepatic tumor associated with oral contraceptives.Br Med J 4:496–498, 1975
Christopherson WM: Possible etiologic factors for some malignant hepatic tumors. In Stroehlein JR Romsdahl MM (eds):Gastrointestinal Cancer. New York: Raven Press, 1981, pp 257–269
Goodman ZP, Ishak KG: Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids.Hepatology 2 (4): 440–444, 1982
Govindarajan S, Ashcaval M, Paters RL: Alpha-1-antitrypsin phenotypes in hepatocellular carcinoma.Hepatology 1 (6): 628–631, 1981
Vergalla J, Jones EA, Kew MC: Alpha-1-antitrypsin deficiency and hepatocellular carcinoma.S Afr Med J 64:950–951, 1983
Paradinas FJ, Melia WM, Wilkinson ML, Portmann B, Johnson PJ, Murray-Lyon IM, Williams R: High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.Br Med J 285:840–842, 1982
Sheppard KJ, Bradbury DA, Davies J, Ryrie DR: High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.Br Med J 286(6358): 57, 1983
Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut S: Copper and copper-binding protein in fibrolamellar liver cell carcinoma.Cancer 51:97–100, 1983
Chuong JJ, Livestone EM, Barwick KW: The histologic and clinical indicators of prognosis in hepatoma.J Clin Gastroenterol 4(6): 547–552, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francis, I.R., Agha, F.P., Thompson, N.W. et al. Fibrolamellar hepatocarcinoma: Clinical, radiologic, and pathologic features. Gastrointest Radiol 11, 67–72 (1986). https://doi.org/10.1007/BF02035035
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02035035